These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2163355)

  • 1. Expression of insulin-like growth factor 1 in sarcomas.
    Roholl PJ; Skottner A; Prinsen I; Lips CJ; Den Otter W; Van Unnik JA
    Histopathology; 1990 May; 16(5):455-60. PubMed ID: 2163355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of actin isoforms in sarcomas: an immunohistochemical study.
    Roholl PJ; Elbers HR; Prinsen I; Claessens JA; van Unnik JA
    Hum Pathol; 1990 Dec; 21(12):1269-74. PubMed ID: 2174404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiomatoid "malignant" fibrous histiocytoma: a clinicopathologic study of 158 cases and further exploration of the myoid phenotype.
    Fanburg-Smith JC; Miettinen M
    Hum Pathol; 1999 Nov; 30(11):1336-43. PubMed ID: 10571514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleomorphic soft tissue myogenic sarcomas of adulthood. A reappraisal in the mid-1990s.
    Schürch W; Bégin LR; Seemayer TA; Lagacé R; Boivin JC; Lamoureux C; Bluteau P; Piché J; Gabbiani G
    Am J Surg Pathol; 1996 Feb; 20(2):131-47. PubMed ID: 8554102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant peripheral nerve sheath tumors and spindle cell sarcomas: an immunohistochemical analysis of multiple markers.
    Giangaspero F; Fratamico FC; Ceccarelli C; Brisigotti M
    Appl Pathol; 1989; 7(2):134-44. PubMed ID: 2471540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of bone morphogenetic proteins in bone and soft-tissue sarcomas.
    Yoshikawa H; Rettig WJ; Lane JM; Takaoka K; Alderman E; Rup B; Rosen V; Healey JH; Huvos AG; Garin-Chesa P
    Cancer; 1994 Aug; 74(3):842-7. PubMed ID: 8039112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of smooth muscle markers in so called malignant fibrous histiocytomas.
    Hasegawa T; Hasegawa F; Hirose T; Sano T; Matsuno Y
    J Clin Pathol; 2003 Sep; 56(9):666-71. PubMed ID: 12944549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent expression of smooth muscle markers in malignant fibrous histiocytoma of bone.
    Ueda T; Araki N; Mano M; Myoui A; Joyama S; Ishiguro S; Yamamura H; Takahashi K; Kudawara I; Yoshikawa H
    J Clin Pathol; 2002 Nov; 55(11):853-8. PubMed ID: 12401825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant fibrous histiocytomas in dogs and cats: an immunohistochemical study.
    Thoolen RJ; Vos JH; van der Linde-Sipman JS; de Weger RA; van Unnik JA; Misdorp W; van Dijk JE
    Res Vet Sci; 1992 Sep; 53(2):198-204. PubMed ID: 1332152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intermediate filament proteins and actin isoforms as markers for soft tissue tumor differentiation and origin. I. Smooth muscle tumors.
    Schürch W; Skalli O; Seemayer TA; Gabbiani G
    Am J Pathol; 1987 Jul; 128(1):91-103. PubMed ID: 2440309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 immunohistochemistry in malignant fibrous histiocytomas and other mesenchymal tumours.
    Soini Y; Vähäkangas K; Nuorva K; Kamel D; Lane DP; Pääkkö P
    J Pathol; 1992 Sep; 168(1):29-33. PubMed ID: 1333524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of intermediate filaments in malignant fibrous histiocytomas.
    Hirose T; Kudo E; Hasegawa T; Abe J; Hizawa K
    Hum Pathol; 1989 Sep; 20(9):871-7. PubMed ID: 2550349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myogenic regulatory protein expression in adult soft tissue sarcomas. A sensitive and specific marker of skeletal muscle differentiation.
    Tallini G; Parham DM; Dias P; Cordon-Cardo C; Houghton PJ; Rosai J
    Am J Pathol; 1994 Apr; 144(4):693-701. PubMed ID: 8160771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laminin matrix formation and S-100 protein and/or desmin-positive cells in malignant fibrous histiocytoma (MFH).
    Kosmehl H; Langbein L; Katenkamp D; Vogel W; Berndt A
    Histol Histopathol; 1993 Jul; 8(3):425-8. PubMed ID: 8395262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular classification of synovial sarcomas, leiomyosarcomas and malignant fibrous histiocytomas by gene expression profiling.
    Lee YF; John M; Edwards S; Clark J; Flohr P; Maillard K; Edema M; Baker L; Mangham DC; Grimer R; Wooster R; Thomas JM; Fisher C; Judson I; Cooper CS
    Br J Cancer; 2003 Feb; 88(4):510-5. PubMed ID: 12592363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The comparative role of immunohistochemistry and electron microscopy in the identification of myogenic differentiation in soft tissue pleomorphic sarcomas.
    Franchi A; Massi D; Santucci M
    Ultrastruct Pathol; 2005; 29(3-4):295-304. PubMed ID: 16036884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant fibrous histiocytoma phenotype in pleomorphic sarcoma differentiation in recurrent disease.
    Costa MJ
    Arch Pathol Lab Med; 1994 Feb; 118(2):160-4. PubMed ID: 8311656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is anti-h-caldesmon useful for distinguishing smooth muscle and myofibroblastic tumors? An immunohistochemical study.
    Ceballos KM; Nielsen GP; Selig MK; O'Connell JX
    Am J Clin Pathol; 2000 Nov; 114(5):746-53. PubMed ID: 11068549
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desmin: its value as a marker of muscle derived tumours using a commercial antibody.
    Leader M; Collins M; Patel J; Henry K
    Virchows Arch A Pathol Anat Histopathol; 1987; 411(4):345-9. PubMed ID: 2442886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current soft-tissue sarcoma classifications.
    Daugaard S
    Eur J Cancer; 2004 Mar; 40(4):543-8. PubMed ID: 14962721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.